Halozyme Therapeutics reported $54.81M in Pre-Tax Profit for its fourth fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Pre Tax Profit Change
Agios Pharmaceuticals AGIO:US $ -98.58M 14.32M
Cytokinetics CYTK:US $ -86.75M 56.18M
Immunogen IMGN:US $ -24.14M 13.03M
Intrexon XON:US $ -29.88M 9.76M
IONIS PHARMACEUT IONS:US $ 225M 309M
Minerva Neurosciences NERV:US $ -9.76M 13.35M
Nektar Therapeutics NKTR:US $ -145.65M 16.06M
Peregrine Pharmaceuticals PPHM:US $ 3.52M 2.78M